Immatics (IMTX) Ownership - Who owns Immatics?

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

Paul-Ehrlich-Strasse 15

Phone

+49 707153970

Employees

343

Web

https://www.immatics.com

Details

Group

Domestic Stock Funds

Fundamentals

IMTX

Capitalization

1.18B

P/E Ratio

N/A

Risk (Beta)

1.30

Dividend Yield

N/A

Total Cash

531M

Total Cash/Share

5.15

Total Debt

17.4M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.85%

Revenue

70.9M

ROE

N/A

Book Value

388M

P/B Ratio

2.75

Cash Flow

N/A

Earnings

-0.83

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

1.03M

Current Ratio

3.74

Current Revenue Per Employee

54679.30

Dividends Per Share - Security

N/A

EBITDA

-61.68M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-14.21

Shares Held By Institutions

1.01B

Shares Outstanding - Current

103M

Total Liabilities

239M

Total Volume MTD

N/A

Value

N/A

Gain YTD

8.737

View a ticker or compare two or three

Compare

IMTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For IMTX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for IMTX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer

Industry Biotechnology